
Australian Pharmaceutical Industries Ltd
ASX:API

Fundamental Analysis


Revenue & Expenses Breakdown
Australian Pharmaceutical Industries Ltd
Balance Sheet Decomposition
Australian Pharmaceutical Industries Ltd
Current Assets | 989.8m |
Cash & Short-Term Investments | 38.8m |
Receivables | 589.1m |
Other Current Assets | 361.9m |
Non-Current Assets | 540.2m |
Long-Term Investments | 2.4m |
PP&E | 230.8m |
Intangibles | 126.5m |
Other Non-Current Assets | 180.5m |
Free Cash Flow Analysis
Australian Pharmaceutical Industries Ltd
AUD | |
Free Cash Flow | AUD |
Earnings Waterfall
Australian Pharmaceutical Industries Ltd
Revenue
|
4B
AUD
|
Cost of Revenue
|
-3.5B
AUD
|
Gross Profit
|
496.6m
AUD
|
Operating Expenses
|
-472.7m
AUD
|
Operating Income
|
23.9m
AUD
|
Other Expenses
|
-22.5m
AUD
|
Net Income
|
1.4m
AUD
|
API Profitability Score
Profitability Due Diligence
Australian Pharmaceutical Industries Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Score
Australian Pharmaceutical Industries Ltd's profitability score is 42/100. The higher the profitability score, the more profitable the company is.
API Solvency Score
Solvency Due Diligence
Australian Pharmaceutical Industries Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Australian Pharmaceutical Industries Ltd's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
API Price Targets Summary
Australian Pharmaceutical Industries Ltd
Dividends
Current shareholder yield for API is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?